Precision therapy in congenital long QT syndrome
- 27 June 2022
- journal article
- research article
- Published by Elsevier in Trends in Cardiovascular Medicine
- Vol. 34 (1) , 39-47
Abstract
No abstract availableKeywords
Funding Information
- Mayo Clinic (UL1TR002377)
- National Center for Advancing Translational Sciences
- National Institutes of Health
This publication has 31 references indexed in Scilit:
- Long-QT SyndromeCirculation: Arrhythmia and Electrophysiology, 2012
- Mutation and gender-specific risk in type 2 long QT syndrome: Implications for risk stratification for life-threatening cardiac events in patients with long QT syndromeHeart Rhythm, 2011
- Risk for Life-Threatening Cardiac Events in Patients With Genotype-Confirmed Long-QT Syndrome and Normal-Range Corrected QT IntervalsJACC, 2011
- Propranolol Blocks Cardiac and Neuronal Voltage-Gated Sodium ChannelsFrontiers in Pharmacology, 2010
- Prevalence of the Congenital Long-QT SyndromeCirculation, 2009
- Genotype-Phenotype Aspects of Type 2 Long QT SyndromeJACC, 2009
- Risk Stratification in the Long-QT SyndromeNew England Journal of Medicine, 2003
- Genotype-Phenotype Correlation in the Long-QT SyndromeCirculation, 2001
- Influence of the Genotype on the Clinical Course of the Long-QT SyndromeNew England Journal of Medicine, 1998
- The long Q-T syndromeAmerican Heart Journal, 1975